{"abstract":"The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the U.S. and foreign Patents and Patent Applications listed in the Supplementary Information section of this notice to BioE Holdings Inc. (parent company, Biological E Ltd.) located in Los Altos, California.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2019/02/07/2019-01430.html","cfr_references":[],"citation":"84 FR 2555","comment_url":null,"comments_close_on":"2019-02-22","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center on or before February 22, 2019 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2019-01430","effective_on":null,"end_page":2556,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2019/02/07/2019-01430.xml","html_url":"https://www.federalregister.gov/documents/2019/02/07/2019-01430/prospective-grant-of-an-exclusive-patent-license-virus-like-particles-vaccines-against-human","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2019-01430?publication_date=2019-02-07","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2019-02-07/2019-01430/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":405,"last_updated":"2026-08-23 20:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2019-02-07/pdf/2019-01430.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2019-01430.pdf?1549460731","publication_date":"2019-02-07","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2019/02/07/2019-01430.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T23:28:53Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":2555,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Virus-Like Particles Vaccines Against Human Polyomaviruses, BK Virus (BKV) and JC Virus (JCV)","toc_doc":"Virus-Like Particles Vaccines Against Human Polyomaviruses, BK Virus and JC Virus","toc_subject":"Prospective Grant of an Exclusive Patent License:","topics":[],"type":"Notice","volume":84}